Who and whatThe talk is being given by Amy Clark of U Penn. She is likely the PI or senior trial coordinator for this trial.
She is Deputy director of clinical trials and an Assistant Prof in U penn medical school and hospitals.
Note the title of the talk:
BRACELET-1 (PrE0113): Inducing an inflammatory phenotype in metastatic HR+/HER2- breast cancer with the oncolytic reovirus pelareorep in combination with paclitaxel and avelumab.
I would not be surprised if this talk focused on what is mentioned in the first part of the title: inducing an inflamed phenotype. Maybe she will not be reviewing the deeper reults of the trial in terms of outcome measures. Those might wait, or be addressed separately.